SOP-QA-30 V Scope
|
|
- Samuel Heath
- 6 years ago
- Views:
Transcription
1 Title: Effective Date: Review Date: Author: Joanne Rodger, Senior R&D Manager QA Approval: Richard Cowie, QA Manager Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head of School Document History Version Description of update Date Effective 1 Change of number for Q-Pulse Reformatted Reference to Device Trials at 1.1 and 3.1 Removal of reference to Compliance report at 3.2 Definition of MHRA findings at Scope 1.1 This SOP applies to Clinical Trials of Investigational Medicinal Products (CTIMPs) that are within the scope of the Medicines for Human Use (Clinical Trials) Regulations 2004, as amended and medical device trials sponsored, co-sponsored or hosted by the University of Aberdeen (UoA) and/or NHS Grampian (NHSG), which are subject to inspection by the MHRA. 1.2 This SOP applies to all research team members and staff and departments supporting, coordinating or participating in CTIMPs or Medical device Trials sponsored, co-sponsored or hosted by UoA and/or NHSG. 2. Responsibilities Sponsor Research Governance Chief Investigator Support researchers in preparation and participation in. Inform relevant researchers and UoA/NHSG staff of impending inspections. Ensure documentation is accurate, up to date and inspection ready at all times. Provide necessary documentation to the Sponsor for preparation of an inspection dossier or to MHRA inspectors upon request. 3. Procedure Medicines and Healthcare products Regulatory Agency (MHRA) 3.1 The MHRA conduct three types of Good Clinical Practice (GCP) inspection. Only two of these types are applicable to non-commercial research; Risk based inspection uses previous inspection history information, organisational changes and any intelligence gathered, to determine an organisation s control of their risk. The resulting risk assessments will be categorised into high, medium and low risk. Inspections are prioritised for organisations with the highest risk category. However, for MHRA internal control purposes, a small proportion of organisations from the medium and low risk categories shall be randomly selected for Page 1 of 5
2 inspection. The majority of GCP inspections conducted by the MHRA are conducted under the Statutory GCP-risk-based inspection programme and are either: Systems Inspections the site(s) or Sponsor is selected for inspection as part of a routine inspection programme of systems employed in the conduct of the trial. Study Specific Inspections - the site(s) or Sponsor is selected for inspection as part of a routine inspection programme relating to a specific trial Triggered inspections (for cause) the site is selected for inspection due to suspicion of significant contractual or regulatory non-compliance, scientific misconduct or fraud. In rare circumstances, notification of triggered inspections may not be given in advance, nor the inspection plan shared with the organisation. Notification of inspection by the MHRA Study specific or triggered inspections 3.2 The CI/PI may be formally notified by the MHRA that a particular clinical trial shall be subject to either a routine study specific GCP inspection or a triggered inspection. In such circumstances the Sponsor/R&D should be notified immediately on The sponsor/r&d shall advise on the action to be followed. 3.3 In rare circumstances the MHRA may arrive to undertake a triggered inspection. In such circumstances the Sponsor/R&D should be notified immediately on The sponsor/r&d shall advise on the action to be followed. Systems inspections 3.4 The Sponsor is formally notified by the MHRA that the organisation or site has been selected for an inspection. 3.5 The formal notice of inspection will request a dossier detailing activities performed by the organisation, or site, to be submitted by a date specified by the MHRA. This dossier shall list the documents that are required by the MHRA prior to the inspection. 3.6 An individual from the organisation or site must be nominated to be Inspection Coordinator and shall be responsible for liaising with the MHRA to ensure coherent communication on matters relating to the inspection. 3.7 On submission of the dossier the MHRA shall acknowledge receipt of the complete dossier. They shall advise of the potential inspection date and may request further information. Preparation for an MHRA inspection 3.8 The MHRA shall provide a proposed timetable for the inspection detailing the departments which may be inspected and staff who shall be interviewed. The inspection coordinator shall inform departments/individuals as soon as possible and ensure that staff shall be available for interview. If the proposed timetable is not suitable, the inspection coordinator shall advise the MHRA. 3.9 For sponsor wide system inspections, the Sponsor must ensure all relevant staff are appropriately prepared for the MHRA inspection. Page 2 of 5
3 Documentation required for an MHRA inspection 3.10 The Sponsor, CI and relevant staff collectively must ensure that all appropriate documentation requested by the MHRA is available The documentation that may be reviewed includes, but is not limited to: Closed minutes from Data Monitoring Committee (DMC) available on request to authorised personnel as appropriate. Completed Case Report Form (CRF) Completed consent forms along with relevant Participant Information Sheet Insurance Investigator Site File (ISF) Laboratory records Patient hospital records/source documentation (If there are legitimate reasons why a patient s hospital notes cannot be available, this must be explained, if possible in advance of the inspection) Pharmacy drug accountability records Publications arisen from the trials Sponsor committee minutes Sponsor risk assessment Sponsor SOPs Training Records Trial Contracts Trial Databases Trial Master File (TMF) Study specific SOPs. (The above list includes any documents that may have been archived). During an MHRA inspection 3.12 The CI and staff from relevant departments must make themselves available during inspection, should they be required by the inspector(s) to provide information or documentation The MHRA Inspector(s) must be accompanied at all times during their visits to the relevant departments. The Inspector(s) shall adhere to guidelines for preparation of entry into restricted or high risk areas ie they shall follow any hand washing and dress code guidelines Interviewees shall answer MHRA Inspector(s) questions honestly and succinctly to the best of their knowledge Interviewees may update or clarify information given during an interview at any time throughout the inspection via the Inspection Coordinator All interviews shall be attended by a scribe to record the discussions During an interview the MHRA inspector(s) may request a specific document or piece of information. Any such request shall be conveyed to the appropriate personnel and the document delivered to the inspector(s). Page 3 of 5
4 3.18 A record shall be kept of any documentation given to the inspector(s). Close-out of an MHRA inspection 3.19 At the end of the inspection, a closeout meeting shall take place and the inspector(s) shall provide verbal feedback on the findings A detailed written report shall be provided by the MHRA within 30 working days of the inspection. The written report shall document all findings from the inspection as: Critical: a deficiency that adversely affects the rights, safety or well-being of patients, or that poses a potential risk to public health, or that represents a serious violation of applicable legislation and guidelines. All such findings are reviewed by the MHRA and may be recommended for prosecution by the Crown Office and Procurator Fiscal Service (COPFS). Major: a deficiency that could potentially affects the rights, safety or well-being of patients, or that could potentially pose a risk to public health, or that represents a violation of applicable legislation and guidelines. Minor: a deficiency that would not be expected to adversely affect the rights, safety or well being of patients A response to the written report is expected within the timeline specified by the inspector(s); usually 30 calendar days. This response should be coordinated by the Inspection Coordinator as appropriate A dialogue may be held with the MHRA to clarify findings and proposed Corrections and Corrective and Preventative Actions (CAPAs). The final written response to the MHRA shall document Corrections and CAPAs and any response timeline When the MHRA are satisfied with the response they will formally accept the CAPA plan, close out the Inspection and issue a GCP inspection statement. Post MHRA inspection follow-up 3.24 An overview of the MHRA Inspection shall be disseminated to researchers by the Research Governance Manager and/or Quality Assurance Manager Any Corrections and CAPAs in relation to inspected projects shall be discussed with the CI and the researcher team as appropriate Any Corrections and CAPAs in relation to Sponsor systems, procedures, SOPs or other Sponsor matters shall be addressed by the relevant governance committee(s) Appropriate close out of all CAPAs shall be overseen by Sponsor through the Clinical Research Oversight Group (CROG). 4. Abbreviations and definitions CAPA/CCAPA CI (Correction and) Corrective And Preventive Action Chief Investigator Page 4 of 5
5 CTIMP MHRA PI TMF Clinical Trial of Investigational Medicinal Product Medicines and Healthcare products Regulatory Agency* Principal Investigator Trial Master File 5. Related documentation and references SOP-QA-2 SOP-QA-7 SOP-QA-15 SOP-QA-32 Training record Trial Master File Management of Medicinal Products used in research Archiving *An executive agency of the Department of Health in the United Kingdom which is responsible for regulating medicines, medical devices and blood components for transfusion in the UK. The MHRA is the competent authority in the UK responsible for human medicines and is responsible for ensuring organisations comply with good clinical practice (GCP) standards. The majority of MHRA GCP inspections are carried out under the risk-based compliance programme. This uses information available to the MHRA to determine an organisation s risk and select the highest risk organisations for inspection. In addition a small number of low risk organisations are also selected for routine inspection. Page 5 of 5
Standard Operating Procedures (SOP) Research and Development Office
Standard Operating Procedures (SOP) Research and Development Office Title of SOP: GCP Inspection Procedures (MHRA) SOP Number: 15 Version Number: 2.0 Supercedes: 1.0 Effective date: August 2013 Review
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Site Initiation SOP-RES-010 Version Number 2 Issue Date 15 Apr 2016 Effective Date 26 May 2016 Review Date 26 May 2018 Author(s) Reviewer(s) Rachelle
More informationStandard Operating Procedure CPFT/SOP003 Serious Breach of Protocol or GCP in CTIMPs
Standard Operating Procedure CPFT/SOP003 Serious Breach of Protocol or GCP in CTIMPs Author: Sponsor/Executive: Responsible committee: Ratified by: Consultation & Approval: (Committee/Groups which signed
More informationSTANDARD OPERATING PROCEDURE SOP 720 RISK ASSESSMENT OF TRIALS SPONSORED. BY THE NNUH and UEA
STANDARD OPERATING PROCEDURE SOP 720 RISK ASSESSMENT OF TRIALS SPONSORED BY THE NNUH and UEA Version 1.0 Version date 13.12.2016 Effective date 13.12.2016 Number of pages 11 pages Review date November
More informationAnnual Progress and Safety Reporting SOP for HEY-sponsored CTIMPs
R&D Department Annual Progress and Safety Reporting SOP for HEY-sponsored CTIMPs Hull and East Yorkshire Hospitals NHS Trust 2010 All Rights Reserved No part of this document may be reproduced, stored
More informationMHRA Pharmacovigilance System Master File (PSMF) Inspection Findings
MHRA Pharmacovigilance System Master File (PSMF) Inspection Findings Gretel Sakyi Medical Information and Patient Safety Manager AstraZeneca UK 07 June 2018 Agenda MHRA inspections How inspectors use the
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
SOP details SOP title: SOP number: SOP category: Version number: 03 Version date: 19 December 2016 Effective date: 19 January 2017 Revision due date: 19 January 2020 NEWCASTLE CLINICAL TRIALS UNIT STANDARD
More informationResearch & Development. J H Pacynko and J Illingworth. Research, pharmacy and R&D staff
Department Title of SOP Research & Development Safety reporting SOP SOP reference no: R&D GCP SOP 07 Authors: Current version number and date: J H Pacynko and J Illingworth Version 9, 31.01.18 Next review
More informationMHRA Pharmacovigilance Inspections: Prepare and Manage for Success
MHRA Pharmacovigilance Inspections: Prepare and Manage for Success Created and Presented by Miranda Dollen Vice President, Pharmacovigilance & EEA QPPV Mapi 2016, All Rights Reserved 2 Prepare and Manage
More informationStandard Operating Procedure Research Governance
Queen s University Belfast Research and Enterprise Standard Operating Procedure Research Governance Title: Application to MHRA for Clinical Trials Authorisation SOP Reference QUB-ADRE-OlO Date prepared
More informationl Chief Investigator/R & D Committee member
North Staffordshire Combined Healthcare '~l:~j Breach of Protocol or Good Clinical Practice SOP Reference R&D-SOP-SOS-002 Version Number Effective Date 19'" February 2010 Review Date 18 m February 2012
More informationDATA MONITORING COMMITTEE & TRIAL STEERING COMMITTEE CHARTERS
DATA MONITORING COMMITTEE & TRIAL STEERING COMMITTEE CHARTERS DOCUMENT NO.: CR015 v1.0 AUTHOR: Lorn Mackenzie ISSUE DATE: 31 January 2017 EFFECTIVE DATE: 14 February 2017 1 INTRODUCTION 1.1 The Academic
More informationStandard Operating Procedure. Selection of studies performed in compliance with Good Laboratory Practice for audit purposes
Scope To describe the procedure for EFSA to request on a yearly or ad-hoc basis the performance of GLP studies audits by the GLP Monitoring Authorities. To lay down criteria for the selection of the GLP
More informationTrust Policy 218 Ionising Radiation Safety Policy
Trust Policy 218 Ionising Radiation Safety Policy Purpose Date Version August 2016 7 To ensure that Plymouth Hospitals NHS Trust complies with all relevant legislation with regard to the use of ionising
More informationTERMS AND CONDITIONS NATIONAL GOOD LABORATORY PRACTICE (GLP) COMPLIANCE MONITORING AUTHORITY
TERMS AND CONDITIONS OF NATIONAL GOOD LABORATORY PRACTICE (GLP) COMPLIANCE MONITORING AUTHORITY FOR OBTAINING AND MAINTAINING ITS GLP CERTIFICATION BY A TEST FACILITY Document No.GLP-101 Version/Issue
More informationMonitoring and re-inspection of local authority children s services judged inadequate
Monitoring and re-inspection of local authority children s services judged inadequate Inspectors handbook This guidance describes the main activities that social care Her Majesty s Inspectors (HMI) undertake
More informationUNIVERSITY OF LEICESTER, UNIVERSITY OF LOUGHBOROUGH & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH & DEVELOPMENT SUPPORT OFFICE
UNIVERSITY OF LEICESTER, UNIVERSITY OF LOUGHBOROUGH & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH & DEVELOPMENT SUPPORT OFFICE STANDARD OPERATING PROCEDURES University of Leicester (UoL)
More informationSection 32: BIMM Institute Student Disciplinary Procedure
Section 32: BIMM Institute Student Disciplinary Procedure Introduction Academic Development & Quality Assurance Manual This Student Disciplinary Procedure provides a framework for the regulation of BIMM
More informationLEAF Marque Assurance Programme
Invisible ISEAL Code It is important that the integrity of the LEAF Marque Standard is upheld therefore the LEAF Marque Standards System has an Assurance Programme to ensure this. This document outlines
More informationWorkplace Drug and Alcohol Policy
Workplace Drug and Alcohol Policy January 2017 This Drug and Alcohol Policy is intended for and includes but is not limited to all Students, Contractors and all others either directly or indirectly engaged
More informationCTO Establishment Inspections. an Atlantic update - Tissues
Transplant Atlantic CTO Establishment Inspections an Atlantic update - Tissues October 14, 2010 Compliance & Enforcement Deliver a national compliance and enforcement program, pursuant of the Food & Drugs
More informationORDER of the Minister of Health No. 269/2017 of 14 March 2017 on mandatory provision of medicinal product adequate and continuous supplies
ORDER of the Minister of Health No. 269/2017 of 14 March 2017 on mandatory provision of medicinal product adequate and continuous supplies ISSUING BODY: The Ministry of Health published in: the Official
More informationPATIENT GROUP DIRECTION PROCEDURE
PATIENT GROUP DIRECTION PROCEDURE Date approved 2 October 2015 Version 3 Approved by Yvette Oade, Chief Medical Officer Procedure Lead Clinical Governance Lead - Medicines Management Procedure Author Karen
More informationSTANDARD OPERATING PROCEDURE
Research Department STANDARD OPERATING PROCEDURE SOP Number C117 Version Number 2.1 Effective Date 01 Sept 2018 Author Angela Pinder Related SOPs C108: Sponsorship C109: Code Break C118: Risk Assessment
More informationInformed Consent Procedures and Writing Informed Consent Forms
STANDARD OPERATING PROCEDURE Informed Consent Procedures and Writing Informed Consent Forms Standard Operating Procedure Western Health SOP reference 006 Version: 2.0 dated December 2015 Effective Date
More informationMemorandum of Understanding
Memorandum of Understanding between the Welsh Ministers and the Chief Inspector of the Care and Social Services Inspectorate Wales and the Chief Executive of Healthcare Inspectorate Wales July 2017 This
More informationDrug and Alcohol Policy
Drug and Alcohol Policy Purpose Skillset Pty Ltd ( Skillset ) is committed to providing a safe and healthy work environment, so far as is reasonably practicable in which all workers are treated fairly,
More informationPATIENT GROUP DIRECTIONS POLICY
PATIENT GROUP DIRECTIONS POLICY To be read in conjunction with the Medicines Policy and the Controlled Drugs Policy Version: 5 Ratified by: Senior Managers Operations Group Date ratified: August 2015 October
More informationIn 2013, Her Majesty s Inspectorate of Constabularies published Stop and Search Powers: Are the police using them effectively and fairly?
STOP & SEARCH POWERS Are the police using them effectively and fairly? In 2013, Her Majesty s Inspectorate of Constabularies published Stop and Search Powers: Are the police using them effectively and
More informationONR GUIDE. The Role of the UK National Coordinators for International Operating Experience Report Systems. ONR-OPEX-GD-003 Revision 3
Title of document ONR GUIDE The Role of the UK National Coordinators for International Operating Experience Report Systems Document Type: Unique Document ID and Revision No: ONR Guide ONR-OPEX-GD-003 Revision
More informationMini Summit XIV: Clinical Trial Disclosure and Results Reporting Liability under FDAAA, Section 801
Mini Summit XIV: Clinical Trial Disclosure and Results Reporting Liability under FDAAA, Section 801 Jarilyn Dupont, JD Director of Regulatory Policy, Office of Policy Office of Commissioner, U.S. Food
More informationSTANDARD OPERATING PROCEDURE
Research Department STANDARD OPERATING PROCEDURE SOP Number C117 Version Number 1.3 Effective Date Author Anna Leesley Angela Pinder Related SOPs C108: Sponsorship C109: Code Break B131: Monitoring of
More informationCare and Social Services Inspectorate Wales
Care and Social Services Inspectorate Wales Service Regulation and Inspection Guidance on inspecting welfare provision in boarding schools, residential special schools and accommodation of students under
More informationPatient Group Directions Policy
Patient Group Directions Policy Category: Summary: Equality Analysis undertaken: Valid From: Date of Next Review: Approval Date/ Via: Distribution: Related Documents: Author(s): Further Information: This
More informationAGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION. (Moscow, 23 December 2014)
AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION (Moscow, 23 December 2014) Member States of the Eurasian Economic Union, hereinafter referred
More informationWILTSHIRE POLICE FORCE PROCEDURE
WILTSHIRE POLICE FORCE PROCEDURE Ethical Interviews Effective from: August 2012 Version: 3.0 Next Review Date: August 2014 TABLE OF CONTENTS PROCEDURE OVERVIEW... 3 GLOSSARY OF TERMS... 3 STRATEGIC PRIORITIES...
More informationResearch Licence Renewal Inspection Report
Research Licence Renewal Inspection Report Project Title The vitrification of blastocysts following biopsy at the earlycleavage stage or blastocyst stage of embryo development A Pilot Study Research Licence
More informationPIC/S GUIDANCE ON CLASSIFICATION OF GMP DEFICIENCIES
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 040-1 3 Appendices 1 January 2019 PIC/S GUIDANCE ON CLASSIFICATION OF GMP DEFICIENCIES PIC/S January 2019 Reproduction
More informationAUDIT TOOL FOR SELF INSPECTION OF COMPLIANCE WITH QUALITY MANAGEMENT SYSTEM FOR PATIENT GROUP DIRECTIONS
AUDIT TOOL FOR DISPENSING SERVICES COMPILED BY: Lynn Morrison ISSUE 1 CHECKED BY: Colette Byrne NUMBER: ISSUE DATE: 01.12.07 SUPERSEDES: NEW REVIEW DATE: 01.12.09 AUDIT TOOL FOR SELF INSPECTION OF COMPLIANCE
More informationPOLICIES & PROCEDURES
Policy Name: Page 1 of 7 I. POLICY Evidence-based clinical research regarding influenza has shown that the best method for prevention and control of seasonal influenza is vaccination. The purpose of this
More informationGLP Update and Hot Topics
GLP Update and Hot Topics RQA Annual Conference Mark Goodwin 9 Nov 2016 Introduction International GLP Updates OECD including MAD Agreement EC/ EMA US FDA & US EPA UK GLP Update MHRA MHRA GLP Deficiencies
More informationPolicy and Procedure for the Development, Approval and Implementation of Patient Group Directions in NHS Haringey Clinical Commissioning Group
BEFORE USING THIS POLICY ALWAYS ENSURE YOU ARE USING THE MOST UP TO DATE VERSION Policy and Procedure for the Development, Approval and Implementation of Patient Group Directions in NHS Haringey Clinical
More informationQuality, Safety and Sourcing in Unlicensed Medicines
Quality, Safety and Sourcing in Unlicensed Medicines with Andrew Trouton Managing Director, UL Medicines Agenda Welcome What is an unlicensed medicine? When should you consider using an unlicensed medicine?
More informationAngelman s Inc.
STATE OF CALIFORNIA DEPARTMENT OF CALIFORNIA HIGHWAY PATROL CONTROLLED SUBSTANCES & ALCOHOL TESTING COMPLIANCE CHECKLIST DRIVER RECORDS - CONTROLLED SUBSTANCES AND ALCOHOL TESTING Do you ensure that all
More informationControl of Substances Hazardous to Health (COSHH) Regulations 2002
Control of Substances Hazardous to Health (COSHH) Regulations 2002 1. Purpose This document provides guidance to staff on how to comply with the COSHH Regulations 2002 (as amended) and in particular informs
More informationClassification Rules and Regulations
World Para Athletics Classification Rules and Regulations March 2017 Official Partners of World Para Athletics www.worldparaathletics.org @ParaAthletics ParalympicSport.TV /ParaAthletics Organisation Part
More informationMonday, 22 January 2018 HFEA, 10 Spring Gardens, London SW1A 2BU
Monday, 22 January 2018 HFEA, 10 Spring Gardens, London SW1A 2BU Panel members Members of the Executive External adviser Caylin Joski-Jethi (Chair) Jessica Watkin Helen Crutcher Bernice Ash Nana Gyamfi
More informationPowys teaching Health Board. Local Healthcare Professionals Forum. Terms of Reference - DRAFT
1. Purpose Powys teaching Health Board Local Healthcare Professionals Forum Terms of Reference - DRAFT As an Advisory Group of Powys teaching Health Board the Forum is accountable to the Health Board and
More informationClassification Rules and Regulations
World Para Swimming Classification Rules and Regulations January 2018 2018 International Paralympic Committee ALL RIGHTS RESERVED Official Approved Supplier of World Para Swimming Equipment www.worldparaswimming.org
More informationBMA INFORMATION BULLETIN No. 23. International Safety Management (ISM) Code
BMA INFORMATION BULLETIN No. 23 International Safety Management (ISM) Code Guidance and instructions for Ship-owners, Managers, Masters, Bahamas Recognised Organisations and Bahamas Approved Inspectors
More information1.5 Ensure the aims and outcomes of the service are understood and shared by all stakeholders.
Job Description JOB TITLE: Senior Peer Support Worker (Ref: 12/150) LOCATION: Portsmouth ACCOUNTABLE TO: Service Manager ACCOUNTABLE FOR: Peer Support Team BRIEF PURPOSE: Encouraging and supporting a network
More informationExecutive Summary for Executive Licensing Panel 20 May Dr Kamal Ahuja. Follow-up inspection 14 April 2010
Summary for Licensing Panel 20 May 2010 Centre number 0011 Centre name The London Sperm Bank Person Responsible Dr Kamal Ahuja Background Follow-up inspection 14 April 2010 1. The London Sperm Bank underwent
More informationCOMPETENT AUTHORITY (UK) MEDICAL DEVICES DIRECTIVES GUIDANCE NOTES FOR MANUFACTURERS OF DENTAL APPLIANCES
COMPETENT AUTHORITY (UK) 10 EC MEDICAL DEVICES DIRECTIVES GUIDANCE NOTES FOR MANUFACTURERS OF DENTAL APPLIANCES (CUSTOM MADE DEVICES) Updated March 2008 CONTENTS PAGE Introduction 3 Definition of dental
More informationNHSScotland Psychology Services
Publication Report NHSScotland Psychology Services Workforce Information as at 31st March 2011 28 June 2011 A National Statistics Publication for Scotland Contents Contents... 1 About ISD... 2 About NES...
More informationIPC Athletics. Classification Rules and Regulations
I P C AT H L E T I C S IPC Athletics Classification Rules and Regulations September 2011 IPC ATHLETICS CLASSIFICATION RULES AND REGULATIONS The IPC Athletics Classification Rules and Regulations are integral
More informationAnnex II - List of enforceable provisions of REACH and CLP
Annex II - List of enforceable provisions of REACH and CLP The provisions below are listed according to the sections of the main report, together with the Titles of the Regulation in the case of REACH.
More informationEFSA PRE-SUBMISSION GUIDANCE FOR APPLICANTS INTENDING TO SUBMIT APPLICATIONS FOR AUTHORISATION OF HEALTH CLAIMS MADE ON FOODS
EFSA PRE-SUBMISSION GUIDANCE FOR APPLICANTS INTENDING TO SUBMIT APPLICATIONS FOR AUTHORISATION OF HEALTH CLAIMS MADE ON FOODS Last updated (Rev.): 21 December 2007 Publication Date: 14 March 2007 NOTES
More informationSELF ASSESSMENT 2 15
SELF ASSESSMENT 2 15 Why Self Assessment? Self assessment contributes to continuous improvement by providing a structured opportunity to assess performance and identify improvements. Self assessment helps
More informationAustralian Sonographer Accreditation Registry (ASAR) Policy & Procedures 6 - Reporting Accreditation Decisions
1. Preamble Australian Sonographer Accreditation Registry (ASAR) ASAR s objective is to promote high standards of medical sonography in Australia which includes setting uniform, minimum standards of Sonographer
More informationDE-DESIGNATION OF YELLOW FEVER VACCINATION CENTRES
DE-DESIGNATION OF YELLOW FEVER VACCINATION CENTRES January 2014 INDEX Page 1. Introduction 3 2. De-designating a YFVC 4 3. The de-designation process 5-6 4. Repeated breaches of the standards for designation
More informationPersonal information, for purposes of this Policy, includes any information which relates to an identified or an identifiable person.
PART I: INTRODUCTION AND BACKGROUND Purpose This Data Protection Binding Corporate Rules Policy ( Policy ) establishes the approach of Fluor to compliance with European data protection law and specifically
More informationSINGLE USE MEDICAL DEVICES POLICY
SINGLE USE MEDICAL DEVICES POLICY First Issued by/date BWW /BKW March 2001 Issue Version Purpose of Issue/Description of Change Planned Review Date 2 Update May 2011 Named Responsible Officer:- Approved
More informationNANDTB-F012 Rev 0 Audit Checklist
NANDTB-F012 Rev 0 Audit Checklist 1. Foreword Minimum Requirements for the Structured Training of Non-Destructive Testing Institutes This document is based upon CEN Technical Report 25108:2006, which is
More informationIPC Athletics Classification Rules and Regulations
IPC Athletics Classification Rules and Regulations February 2013 International Paralympic Committee Adenauerallee 212-214 Tel. +49 228 2097-200 www.paralympic.org 53113 Bonn, Germany Fax +49 228 2097-209
More informationSafeguarding Business Plan
Safeguarding Business Plan 2015-2018 Contents 1. Introduction 2. The Care Act 3. Organisational Development 4. Vision, Values and Strategic Objectives 5. Financial Plan 6. Appendix A Action Plan 7. Appendix
More informationStandard operating procedure
Standard operating procedure Title: Preparation of an initial European Public Assessment Report (EPAR) for a human medicinal product following positive or negative opinion Status: PUBLIC Document no.:
More informationEnvironment, Health and Safety Management System. Management of Contractors Procedure
Environment, Health and Safety Management System Procedure Revision History Revision No. Review Date 1.0 Feb/2018 Description of Change Replacing the Health & Safety Sr. Officer with Health & Safety Specialist/
More informationCancer Council New South Wales: Submission on Public Health (Tobacco) Regulations 2016
Cancer Council New South Wales: Submission on Public Health (Tobacco) Regulations 2016 To whom it may concern, Thank you for the opportunity to submit on the Draft Public Health (Tobacco) Regulations 2016
More informationCare and Social Services Inspectorate Wales. Care Standards Act Inspection Report. ategi Shared Lives Scheme. Cardiff
Care and Social Services Inspectorate Wales Care Standards Act 2000 Inspection Report ategi Shared Lives Scheme Cardiff Type of Inspection Focused Date of inspection Monday, 11 January 2016 Date of publication
More informationCARIBX (UK) LIMITED. Environmental, Health and Safety Management System. Revision: 00 APRIL 2011
CARIBX (UK) LIMITED Environmental, Health and Safety Management System Revision: 00 APRIL 2011 Document Details and Issue Record Rev No. Details Date Author Checked Text 00 Draft 01/04/2011 CJMD Calcs
More informationAnnual Report of Estyn s Audit and Risk Assurance Committee
Annual Report of Estyn s Audit and Risk Assurance Committee 1 Purpose 1.1 This report summarises the main work of the Estyn Audit and Risk Assurance Committee during the period 1 st April 2013 31 st March
More informationStandard Operating Procedure: Early Intervention in Psychosis Access Times
Corporate Standard Operating Procedure: Early Intervention in Psychosis Access Times Document Control Summary Status: New Version: V1.0 Date: Author/Owner: Rob Abell, Senior Performance Development Manager
More informationFriday, 14 July 2017 HFEA, 10 Spring Gardens, London SW1A 2BU
Friday, 14 July 2017 HFEA, 10 Spring Gardens, London SW1A 2BU Panel members Juliet Tizzard (Chair) Anjeli Kara Jessica Watkin Director of Strategy & Corporate Affairs Regulatory Policy Manager Policy Manager
More informationEducation and Training Committee 15 November 2012
Education and Training Committee 15 November 2012 Review of the process of approval of hearing aid dispenser pre-registration education and training programmes. Executive summary and recommendations Introduction
More informationInternational Paralympic Committee Powerlifting Classification Rules and Regulations
IPC POWERLIFTING International Paralympic Committee Powerlifting Classification Rules and Regulations March 2015 IPC Powerlifting Classification Rules and Regulations, version 3 March 2015 International
More informationGisborne District Council Alcohol Control Bylaw 2015
APPENDIX 2 Gisborne District Council Alcohol Control Bylaw 2015 Statement of Proposal May 2015 A569837 Page 1 Introduction This is a Statement of Proposal prepared in accordance with section 83(1)(a) of
More informationIonising Radiation Policy
Ionising Radiation Policy CONTENTS 1. University Policy. 2. Procedures / Guidance. 2.1 Responsibilities of the Deans of Schools and/or Heads of Departments 2.2 Radiation Protection Advisor / Radiation
More informationRECERTIFICATION PROGRAMME FOR CONTINUING PROFESSIONAL DEVELOPMENT OF OPTOMETRISTS
RECERTIFICATION PROGRAMME FOR CONTINUING PROFESSIONAL DEVELOPMENT OF OPTOMETRISTS Background The principal purpose of the Health Practitioners Competence Assurance Act 2003 (Act) is to protect public health
More informationInternational Standard for Athlete Evaluation. July 2015
International Standard for Athlete Evaluation July 2015 International Paralympic Committee Adenauerallee 212-214 Tel. +49 228 2097-200 www.paralympic.org 53113 Bonn, Germany Fax +49 228 2097-209 info@paralympic.org
More informationManaging the risks of clinical trials: the MRC/MHRA approach
Managing the risks of clinical trials: the MRC/MHRA approach Sarah Meredith MRC Clinical Trials Unit at UCL UCL Institute for Clinical Trials and Methodology FCRIN Workshop, Hôpital Saint Louis, Paris
More informationNational Drug and Alcohol Treatment Waiting Times
National Drug and Alcohol Treatment Waiting Times 1 October 31 December 2017 Publication date 27 March 2018 A National Statistics publication for Scotland This is a National Statistics Publication National
More informationCutanea Life Sciences, Inc. Comprehensive Compliance Program
Cutanea Life Sciences, Inc. Comprehensive Compliance Program Cutanea engages in research, development, manufacture and marketing of dermatology products, including commercialization of those products.
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Home Inspections, Compliance, Enforcement, and Criminal Investigations Enforcement Actions Warning Letters Inspections, Compliance, Enforcement, and Criminal Investigations Burzynski Research Institute
More informationGDC Disclosure and Publication Policy
GDC Disclosure and Publication Policy 1 DISCLOSURE AND PUBLICATION POLICY TABLE OF CONTENTS PURPOSE... 4 THE LAW... 4 PUBLICATION OF FITNESS TO PRACTISE INFORMATION... 5 Publication of Conduct and Performance
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Home > Inspections, Compliance, Enforcement, and Criminal Investigations > Enforcement Actions > Warning Letters Inspections, Compliance, Enforcement, and Criminal Investigations Punjwani, Sohail S., M.D.
More information(Legislative acts) REGULATIONS
31.12.2010 Official Journal of the European Union L 348/1 I (Legislative acts) REGULATIONS REGULATION (EU) No 1235/2010 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 15 December 2010 amending, as regards
More informationHearing aid dispenser approval process review Introduction Hearing aid dispenser data transfer... 6
Hearing aid dispenser approval process review 2010 11 Content 1.0 Introduction... 4 1.1 About this document... 4 1.2 Overview of the approval process... 4 2.0 Hearing aid dispenser data transfer... 6 2.1
More informationDay care and childminding: Guidance to the National Standards
raising standards improving lives Day care and childminding: Guidance to the National Standards Revisions to certain criteria October 2005 Reference no: 070116 Crown copyright 2005 Reference no: 070116
More informationZ E N I T H M E D I C A L P R O V I D E R N E T W O R K P O L I C Y Title: Provider Appeal of Network Exclusion Policy
TheZenith's Z E N I T H M E D I C A L P R O V I D E R N E T W O R K P O L I C Y Title: Provider Appeal of Network Exclusion Policy Application: Zenith Insurance Company and Wholly Owned Subsidiaries Policy
More informationNJ RAPID HIV TESTING SUPPORT PROGRAM
PROGRAM OVERVIEW Program Description: Point of Care testing may seem, on its face, simple and 'fool proof', but in a study conducted by HCFA in Colorado and Ohio, quality problems were identified in more
More informationRECERTIFICATION PROGRAMME FOR CONTINUING PROFESSIONAL DEVELOPMENT OF OPTOMETRISTS
RECERTIFICATION PROGRAMME FOR CONTINUING PROFESSIONAL DEVELOPMENT OF OPTOMETRISTS Background The principal purpose of the Health Practitioners Competence Assurance Act 2003 (Act) is to protect public health
More informationUKAS Guidance on the Application of ISO/IEC Dealing with Expressions of Opinions and Interpretations
LAB 13 Expression of opinions & interpretations UKAS Guidance on the Application of ISO/IEC 17025 Dealing with Expressions of Opinions and Interpretations [UKAS Publication ref: LAB 13] Contents Section
More informationOfsted s regulation and inspection of providers on the Early Years Register from September 2012: common questions and answers
Ofsted s regulation and inspection of providers on the Early Years Register from September 2012: common questions and answers Registration Conditions of registration Q. How will I know how many children
More informationCase scenarios: Patient Group Directions
Putting NICE guidance into practice Case scenarios: Patient Group Directions Implementing the NICE guidance on Patient Group Directions (MPG2) Published: March 2014 [updated March 2017] These case scenarios
More informationSafeguarding Children and Young People Policy
Safeguarding Children and Young People Policy Policy Summary This policy outlines our commitment to keeping the children and young people who engage with the Red Cross safe. It outlines the expectations
More informationInformation for applicants for Special Licence
Information for applicants for Special Licence A building consent may be required before a special licence is issued if you intend to use a building that is not normally used as a licensed premises and/or
More informationArticle XIV: MINIMUM CONTINUING EDUCATION FOR DENTISTS AND DENTAL HYGIENISTS
AMENDMENT MARKUP Article XIV: MINIMUM CONTINUING EDUCATION FOR DENTISTS AND DENTAL HYGIENISTS A. Purpose: The Rules in this chapter set forth the requirements and guidelines for minimum continuing education
More informationDarwin Marine Supply Base HSEQ Quality Management Plan
Darwin Marine Supply Base HSEQ Quality Management Plan REVISION SUMMARY Revision Date Comment Authorised 0 29.9.13 Initial input JC 1 12.1.15 General Review JC 2 3 4 5 6 7 8 9 Revision Log Revision No
More informationPROFICIENCY TESTING AND OTHER COMPARISON PROGRAMME REQUIREMENTS FOR CALIBRATION LABORATORIES
PROFICIENCY TESTING AND OTHER COMPARISON PROGRAMME REQUIREMENTS FOR CALIBRATION LABORATORIES Approved By: Chief Executive Officer: Ron Josias Executive - Accreditation: Mpho Phaloane Revised By: Accreditation
More informationIT and Information Acceptable Use Policy
BMI IMpol04 Information Management IT and Information Acceptable Use Policy This is a controlled document and whilst this document may be printed, the electronic version posted on the intranet/shared drive
More information